Literature DB >> 9777608

Isolation and identification of a metabolite of cidofovir from rat kidney.

E J Eisenberg1, G R Lynch, A M Bidgood, K Krishnamurty, K C Cundy.   

Abstract

Cidofovir is an acyclic nucleotide analog with potent and broad-spectrum antiviral activity against adenoviruses and herpesviruses including cytomegalovirus (CMV). Cidofovir undergoes intracellular phosphorylation by host enzymes to cidofovir phosphate and cidofovir diphosphate (the active form). An unidentified metabolite has been observed previously in rat tissues and in urine of rabbits, rats and monkeys dosed with cidofovir. In the present study, this metabolite was isolated from rat kidney following an intravenous dose of 100 mg kg-1 cidofovir. The metabolite (metabolite I) was separated from cidofovir and impurities using extraction on anion-exchange resin followed by preparative normal and reversed-phase high-performance liquid chromatography (HPLC). The isolated metabolite I was subjected to proton, 13C and phosphorus nuclear magnetic resonance (NMR) and matrix-assisted laser desorption/ionization mass spectroscopy, and confirmed to be cidofovir-phosphocholine. The uptake of cidofovir by rat kidney was saturated at an intravenous dose of 100 mg kg-1, probably as a result of saturation of the renal tubular secretion pathway. However, the relative abundance of cidofovir phosphocholine was not affected by dose.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777608     DOI: 10.1016/s0731-7085(97)00162-3

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Solution structure of a DNA duplex containing the potent anti-poxvirus agent cidofovir.

Authors:  Olivier Julien; James R Beadle; Wendy C Magee; Subhrangsu Chatterjee; Karl Y Hostetler; David H Evans; Brian D Sykes
Journal:  J Am Chem Soc       Date:  2011-01-31       Impact factor: 15.419

2.  Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.

Authors:  Haiyan Wang; Jay Chhablani; William R Freeman; James R Beadle; Karl Y Hostetler; Kathrin Hartmann; Laura Conner; Kathy A Aldern; Lindsey Pearson; Lingyun Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

Review 3.  Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.

Authors:  K C Cundy
Journal:  Clin Pharmacokinet       Date:  1999-02       Impact factor: 6.447

4.  Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity.

Authors:  Angela Mally; Sebastian Jarzina
Journal:  Front Toxicol       Date:  2022-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.